NZ605982A - Compositions containing flavones and anthelmintics - Google Patents
Compositions containing flavones and anthelminticsInfo
- Publication number
- NZ605982A NZ605982A NZ605982A NZ60598211A NZ605982A NZ 605982 A NZ605982 A NZ 605982A NZ 605982 A NZ605982 A NZ 605982A NZ 60598211 A NZ60598211 A NZ 60598211A NZ 605982 A NZ605982 A NZ 605982A
- Authority
- NZ
- New Zealand
- Prior art keywords
- group
- anthelmintics
- anthelmintic
- composition
- disclosed
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/351—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom not condensed with another ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Disclosed is a composition comprising a flavone compound of formula I, and an anthelmintic selected from the group comprising: levamisole, macrocyclic lactones selected from the group comprising avermectins or from the group comprising milbemycins, benzimidazole derivatives selected from albendazole, thiabenzole, mebendazole, fenbendazole, oxfendazole, febantal, and oxibendazole, that increases the bioavailable amount of the anthelmintic to treat parasitosis for example nematodes. Also disclosed is the use of the composition for preparing a medicinal product that is able to increase the bioavailability of anthelmintics in nematodes, for the treatment or prevention in a vertebrate of a parasitosis due to a nematode belonging to the Helminths phylum of the Metazoa.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR1054881A FR2961399A1 (en) | 2010-06-18 | 2010-06-18 | COMPOSITIONS BASED ON FLAVONES AND ANTHELMINTHICS |
PCT/FR2011/051334 WO2011157936A1 (en) | 2010-06-18 | 2011-06-10 | Compositions containing flavones and anthelmintics |
Publications (1)
Publication Number | Publication Date |
---|---|
NZ605982A true NZ605982A (en) | 2015-02-27 |
Family
ID=42668745
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NZ605982A NZ605982A (en) | 2010-06-18 | 2011-06-10 | Compositions containing flavones and anthelmintics |
Country Status (6)
Country | Link |
---|---|
EP (1) | EP2582370A1 (en) |
AU (1) | AU2011266864C1 (en) |
FR (1) | FR2961399A1 (en) |
NZ (1) | NZ605982A (en) |
WO (1) | WO2011157936A1 (en) |
ZA (1) | ZA201209745B (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110810415B (en) * | 2019-11-29 | 2021-06-15 | 北京农学院 | Application of kaempferol 3, 4' -diglycoside 7-rhamnoside |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2001003681A2 (en) * | 1999-07-08 | 2001-01-18 | Prendergast Patrick T | Use of flavones, coumarins and related compounds to treat infections |
WO2002069949A2 (en) * | 2001-03-06 | 2002-09-12 | Prendergast Patrick T | Combination therapy for reduction of toxycity of chemotherapeutic agents |
WO2007135592A1 (en) * | 2006-05-19 | 2007-11-29 | The Hong Kong Polytechnic University | Flavonoid dimers and methods of making and using such |
WO2008085995A1 (en) * | 2007-01-09 | 2008-07-17 | Merck & Co., Inc. | Anthelmintic flavones from struthiola argenta |
WO2009018326A2 (en) | 2007-07-31 | 2009-02-05 | Limerick Biopharma, Inc. | Soluble pyrone analogs methods and compositions |
-
2010
- 2010-06-18 FR FR1054881A patent/FR2961399A1/en not_active Withdrawn
-
2011
- 2011-06-10 AU AU2011266864A patent/AU2011266864C1/en not_active Ceased
- 2011-06-10 WO PCT/FR2011/051334 patent/WO2011157936A1/en active Application Filing
- 2011-06-10 EP EP11735482.9A patent/EP2582370A1/en not_active Withdrawn
- 2011-06-10 NZ NZ605982A patent/NZ605982A/en not_active IP Right Cessation
-
2012
- 2012-12-21 ZA ZA2012/09745A patent/ZA201209745B/en unknown
Also Published As
Publication number | Publication date |
---|---|
AU2011266864A1 (en) | 2013-01-10 |
ZA201209745B (en) | 2014-03-26 |
AU2011266864B2 (en) | 2016-02-18 |
FR2961399A1 (en) | 2011-12-23 |
EP2582370A1 (en) | 2013-04-24 |
AU2011266864C1 (en) | 2016-06-02 |
WO2011157936A1 (en) | 2011-12-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EA201390198A1 (en) | Heterocyclic Compound | |
CY1118048T1 (en) | Anti-viral compounds | |
CO6470845A2 (en) | NEW PYRIMIDINE DERIVATIVES AND THEIR USE IN THE TREATMENT OF CANCER AND ADDITIONAL DISEASES | |
BR112012017442A2 (en) | substituted bicyclic triazole derivatives as gamma secretase modulators | |
CY1116328T1 (en) | Derivative 4 - aminopyrimidine and their use as adenosine A2A receptor antagonists | |
AR047993A1 (en) | PHARMACEUTICAL COMPOSITION THAT PIMOBENDAN INCLUDES | |
BR112012000763B8 (en) | pyridin-4-yl derivative compounds, pharmaceutical composition, and uses of a compound | |
SV2009003236A (en) | REPLACED DIHYDROPIRAZOLONES FOR THE TREATMENT OF CARDIOVASCULAR AND HEMATOLOGICAL DISEASES | |
MX2011009847A (en) | Anthelmintic agents and their use. | |
MY152710A (en) | Oral compositions containing extracts of garcinia mangostana l. and related methods | |
CO6640327A2 (en) | Pyrazole compounds as sigma receptor inhibitors | |
UY28726A1 (en) | N-CYCLHEXILIMIDAZOLINONAS SUBSTITUTES.PROCEDIMIENTOS FOR ITS PREPARATION AND ITS USE AS MEDICATIONS. | |
NZ607580A (en) | N-heteroaryl compounds | |
NZ600845A (en) | Compositions comprising macrocyclic lactone compounds and spirodioxepinoindoles | |
BR112012013487A2 (en) | AMANTADINE COMPOSITIONS AND METHODS OF USE | |
CU20130063A7 (en) | PRODUCTION PROCESS OF CYCLIC DEPSIPEPTIDES | |
TN2009000275A1 (en) | Use of substituted pyranone acid derivatives for the treatment of metabolic syndrome | |
BR112012023407A2 (en) | pharmaceutical powder composition for installation, and process for preparing it. | |
DOP2006000062A (en) | PYRIMIDINCARBOXILIC ACID DERIVATIVES AND ITS USE | |
UA103500C2 (en) | Sulfoximine-substituted anilinopyrimidine derivatives as cdk-inhibitors, preparation thereof and use as medicinal agents | |
MX2009009154A (en) | Spiro-pyrano-pyrazole derivatives. | |
UA107183C2 (en) | Phenylamine-isonicotinamide compounds, their applications, pharmaceutical composition containing them, and method of treatment of hyperproliferative | |
WO2011006935A3 (en) | Tetrazole derivatives | |
CU20110161A7 (en) | CYCLOPROPILAMIDE DERIVATIVES DIRECTED AGAINST H3 HISTAMINE RECEIVER | |
MX2011013869A (en) | Anthelmintic agents and their use. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PSEA | Patent sealed | ||
RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 10 JUN 2016 BY AJ PARK Effective date: 20150624 |
|
RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 10 JUN 2017 BY AJ PARK Effective date: 20160513 |
|
LAPS | Patent lapsed |